Contraindicated (1)pentobarbital will reduce the level or impact of cariprazine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is liable for the development and elimination of cariprazine's Energetic metabolites.pentobarbital will reduce the extent or result of buprenorphine subdermal implant by impacting hepatic/